Searched for
CANCER MED
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- In 1937, a chemistry student tasted something sweet on a cigarette, and this led to a sweetener that changed diet foods industryA lab accident in 1937 led to the discovery of cyclamate, an artificial sweetener. It quickly became popular for low-calorie products. Late...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Health services, medical education expansion to be driven by modern tech: Yogi AdityanathUttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding s...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- MrMed sees 50% growth in revenue in FY24It also a 177% increase in gross margins with total losses reducing by 31% compared to the previous fiscal year. Additionally, the percenta...
- Zydus launches anti-cancer generic drug olaparib in IndiaThe drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for a more tailored and effective tre...
- From cancer to rheumatology, online pharmacy MrMed wants to make speciality medicines affordable & accessibleSuper-speciality medicines play an indispensable role in addressing complex health issues, but they often remain ensnared in a web of acces...
- MrMed launches mobile app for access to affordable super-specialty medicinesThis launch will ensure that the patients and caregivers across India have access to over 5,000 speciality medicines.
- RGCB research proves anti-cancer capabilities of black nightshade leaves"The berry-bearing black nightshade shrub is proving to possess the potency to treat liver cancer, as the compound, Uttroside-B isolated fr...
- MedGenome secures $55 million funding led by LeapFrog InvestmentsMedGenome plans to use the funds raised to expand clinical genomic testing to India's tier-2 and tier-3 towns and cities, as well as toward...
- Purposeful innovation: How startups are solving challenges plaguing Indian healthcareIt is important to nurture and support such indigenous innovation in these early days - as they can make India the MedTech innovation hub f...
- Radia to enter NCR mkt with 600-bed hospital in GurgaonCalled PrimaMed, the 600-bed facility is coming up on Golf Course Road and will mark the entry of Nayati Healthcare, which is promoted by N...
- MedGenome Labs gets Rs 192 crore in Series-C RoundThe round also saw participation from Zodius Capital, former Infosys CEO Kris Gopalakrishnan and former Cognizant CEO Lakshmi Narayanan.
- For Indian doctors, it's written in the genes not starsMedGenome has seen the number of samples triple for genetic tests in of samples triple for genetic tests in the last one year.
- Separate regulations needed for medical devices: AdvaMedMedical devices sector in India needs to be regulated in harmonisation with international practises, trade association AdvaMed has said.
- Genetic cause of common breast tumours in women identifiedScientists have uncovered the molecular basis of fibroadenoma, one of the most common benign breast tumours diagnosed in women of reproduct...
Load More
